Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions (Q80878254)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 November 2004

Language	Label	Description	Also known as
English	Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions	scientific article published on 01 November 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15491759%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15491759%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Ursula A. Matulonis

2

object named as

Ursula A Matulonis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15491759%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Chyh-Woei Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15491759%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Mariana C Castells

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15491759%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 November 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15491759%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15491759%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

95

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15491759%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15491759%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

370-376

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15491759%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

Optimal therapy of advanced ovarian cancer: carboplatin and paclitaxel vs. cisplatin and paclitaxel (GOG 158) and an update on GOG0 182-ICON5

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

Treatment of recurrent ovarian cancer: a retrospective analysis of women treated with single-agent carboplatin originally treated with carboplatin and paclitaxel. The Memorial Sloan-Kettering Cancer Center experience.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

A new standard of care for treatment of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

Clinical features of hypersensitivity reactions to carboplatin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

Successful administration of carboplatin in patients with clinically documented carboplatin hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

Hypersensitivity reactions to carboplatin given to patients with relapsed ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

A modified, prolonged desensitization protocol in carboplatin allergy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

Initial experience with a novel desensitization strategy for carboplatin-associated hypersensitivity reactions: carboplatin-hypersensitivity reactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

Carboplatin hypersensitivity: case reports and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

Hypersensitivity reactions to carboplatin. Report of two patients, review of the literature, and discussion of diagnostic procedures and management

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

Mastocytosis: mediator-related signs and symptoms

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

Acute and chronic desensitization of penicillin-allergic patients using oral penicillin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

Antigen-specific desensitization of patients allergic to penicillin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

Death from anaphylaxis to cisplatin: a case report

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

Analysis of patients with epithelial ovarian cancer or fallopian tube carcinoma retreated with cisplatin after the development of a carboplatin allergy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

Specific IgE antibodies to platinum salts in sensitized workers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

based on heuristic

inferred from DOI database lookup

Immediate (type I) allergic responses to platinum compounds

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

based on heuristic

inferred from DOI database lookup

Passive transfer in man and the monkey of Type I allergy due to heat labile and heat stable antibody to complex salts of platinum

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.002

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YGYNO.2004.08.002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15491759%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15491759%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80878254&oldid=2046310729"